Table 2.
Comparison of recurrence patterns and therapeutic modalities for recurrent hepatocellular carcinoma in curatively resected patients (n = 19)
| Analysis of recurrence | Non-survivors (n = 14) | 5-year survivors (n = 5) | P-value |
|---|---|---|---|
| Recurrence, n (%) | 14 (100%) | 4 (80.0%) | |
| Number of nodules in recurrence, n (%) | |||
| <4 | 3 (21.4%) | 4 (100%) | 0.0114 |
| ≥4 | 11 (78.6%) | 0 | |
| Sites of recurrence, n | |||
| Liver | 13 | 3 | |
| Lung | 1 | 1 | |
| Bone | 1 | 1 | |
| Brain | 1 | 0 | |
| Peritoneum | 1 | 0 | |
| Treatment for the first recurrence, n | 0.0364 | ||
| Resection | 0 | 2 | |
| Radiofrequency ablation | 3 | 1 | |
| TACE (+ radiation) | 8 | 1 | |
| Best supportive care | 3 | 0 | |
TACE, transarterial chemoembolization.